{"id":48439,"date":"2026-02-20T05:12:01","date_gmt":"2026-02-20T05:12:01","guid":{"rendered":"https:\/\/www.globalresearch.co.kr\/insight\/neurodegenerative-disease-market-mordor\/"},"modified":"2026-09-25T03:40:53","modified_gmt":"2026-09-24T18:40:53","slug":"neurodegenerative-disease-market-mordor","status":"publish","type":"post","link":"https:\/\/www.globalresearch.co.kr\/insight\/neurodegenerative-disease-market-mordor\/","title":{"rendered":"\uc138\uacc4\uc758 \uc2e0\uacbd\ud1f4\ud589\uc131 \uc9c8\ud658 \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc810\uc720\uc728 \ubd84\uc11d &#8211; \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc804\ub9dd (2026 &#8211; 2031\ub144)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/neurodegenerative-disease-market_1666852607248_neudegenerative_diseases-_MP.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/neurodegenerative-disease-market-size-image-1770982202331.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">1. \uc11c\ub860<\/p>\n<ul>\n<li class=\"toc-level-2\">1.1 \uc5f0\uad6c \uac00\uc815 \ubc0f \uc2dc\uc7a5 \uc815\uc758<\/li>\n<li class=\"toc-level-2\">1.2 \uc5f0\uad6c \ubc94\uc704<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">2. \uc5f0\uad6c \ubc29\ubc95\ub860<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">3. \uc694\uc57d<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">4. \uc2dc\uc7a5 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">4.1 \uc2dc\uc7a5 \uac1c\uc694<\/li>\n<li class=\"toc-level-2\">4.2 \uc2dc\uc7a5 \ub3d9\uc778\n<ul>\n<li class=\"toc-level-3\">4.2.1 \uace0\ub839\ud654 \uc778\uad6c \uc99d\uac00\ub85c \uc778\ud55c \uc9c8\ubcd1 \ubd80\ub2f4 \uac00\uc911<\/li>\n<li class=\"toc-level-3\">4.2.2 \uc9c8\ubcd1 \uc870\uc808 \uce58\ub8cc\uc81c\uc758 \ucd9c\uc2dc \ubc0f \ubcf4\ud5d8 \uc801\uc6a9<\/li>\n<li class=\"toc-level-3\">4.2.3 \uc2e0\uacbd \uc601\uc0c1 \ubc0f \ud608\uc561 \uae30\ubc18 \ubc14\uc774\uc624\ub9c8\ucee4\uc758 \ubc1c\uc804<\/li>\n<li class=\"toc-level-3\">4.2.4 \uc2e0\uacbd\uacfc\ud559 R&amp;D \ud22c\uc790 \ud655\ub300<\/li>\n<li class=\"toc-level-3\">4.2.5 AI \uae30\ubc18 \uc2e0\uaddc \ud45c\uc801 \ubc1c\uad74 \uac00\uc18d\ud654<\/li>\n<li class=\"toc-level-3\">4.2.6 BBB \ud22c\uacfc\ub97c \ud5a5\uc0c1\uc2dc\ud0a4\ub294 \ub1cc \ud45c\uc801 \uc804\ub2ec \ud50c\ub7ab\ud3fc<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.3 \uc2dc\uc7a5 \uc81c\uc57d\n<ul>\n<li class=\"toc-level-3\">4.3.1 \ud6c4\uae30 \uc784\uc0c1 \uc2dc\ud5d8\uc758 \ub192\uc740 \uc2e4\ud328\uc728<\/li>\n<li class=\"toc-level-3\">4.3.2 \ucca8\ub2e8 \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c \ubc0f \uc720\uc804\uc790 \uce58\ub8cc\uc81c\uc758 \uace0\uac00 \uc815\ucc45<\/li>\n<li class=\"toc-level-3\">4.3.3 \uc2e0\ud765 \uc2dc\uc7a5\uc758 \uc81c\ud55c\uc801\uc778 \ubc14\uc774\uc624\ub9c8\ucee4 \uc778\ud504\ub77c<\/li>\n<li class=\"toc-level-3\">4.3.4 \ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130 \uc81c\uc870 \uacf5\uae09\ub9dd \ubcd1\ubaa9 \ud604\uc0c1<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.4 \uacf5\uae09\ub9dd \ubd84\uc11d<\/li>\n<li class=\"toc-level-2\">4.5 \uaddc\uc81c \ud658\uacbd<\/li>\n<li class=\"toc-level-2\">4.6 \uae30\uc220 \uc804\ub9dd<\/li>\n<li class=\"toc-level-2\">4.7 \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1 \uc694\uc778 \ubd84\uc11d\n<ul>\n<li class=\"toc-level-3\">4.7.1 \uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.7.2 \uad6c\ub9e4\uc790\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.7.3 \uacf5\uae09\uc790\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.7.4 \ub300\uccb4\uc7ac\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.7.5 \uacbd\uc7c1 \uac15\ub3c4<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">5. \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc608\uce21 (\uac00\uce58, USD)<\/p>\n<ul>\n<li class=\"toc-level-2\">5.1 \uc801\uc751\uc99d\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.1.1 \ud30c\ud0a8\uc2a8\ubcd1<\/li>\n<li class=\"toc-level-3\">5.1.2 \uc54c\uce20\ud558\uc774\uba38\ubcd1<\/li>\n<li class=\"toc-level-3\">5.1.3 \uadfc\uc704\ucd95\uc131 \uce21\uc0ad \uacbd\ud654\uc99d (ALS)<\/li>\n<li class=\"toc-level-3\">5.1.4 \ub2e4\ubc1c\uc131 \uacbd\ud654\uc99d<\/li>\n<li class=\"toc-level-3\">5.1.5 \ud5cc\ud305\ud134\ubcd1<\/li>\n<li class=\"toc-level-3\">5.1.6 \uc804\uce21\ub450\uc5fd \uce58\ub9e4<\/li>\n<li class=\"toc-level-3\">5.1.7 \ucc99\uc218\uc131 \uadfc\uc704\ucd95\uc99d (SMA)<\/li>\n<li class=\"toc-level-3\">5.1.8 \uae30\ud0c0 \ud76c\uadc0 \uc2e0\uacbd\ud1f4\ud589\uc131 \uc9c8\ud658<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.2 \uc57d\ubb3c \ub4f1\uae09\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.2.1 NMDA \uc218\uc6a9\uccb4 \uae38\ud56d\uc81c<\/li>\n<li class=\"toc-level-3\">5.2.2 \ucf5c\ub9b0\uc5d0\uc2a4\ud14c\ub77c\uc81c \uc5b5\uc81c\uc81c<\/li>\n<li class=\"toc-level-3\">5.2.3 \ub3c4\ud30c\ubbfc \uc791\uc6a9\uc81c<\/li>\n<li class=\"toc-level-3\">5.2.4 \uba74\uc5ed \uc870\uc808\uc81c \/ \ub2e8\uc77c\ud074\ub860 \ud56d\uccb4<\/li>\n<li class=\"toc-level-3\">5.2.5 \uc720\uc804\uc790 \ubc0f \uc138\ud3ec \uce58\ub8cc\uc81c<\/li>\n<li class=\"toc-level-3\">5.2.6 \uc548\ud2f0\uc13c\uc2a4 \uc62c\ub9ac\uace0\ub274\ud074\ub808\uc624\ud0c0\uc774\ub4dc \ubc0f RNAi<\/li>\n<li class=\"toc-level-3\">5.2.7 \uae30\ud0c0 \uc57d\ubb3c \ub4f1\uae09<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.3 \ubd84\uc790 \uc720\ud615\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.3.1 \uc800\ubd84\uc790 \uc57d\ubb3c<\/li>\n<li class=\"toc-level-3\">5.3.2 \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c \ubc0f \ub2e8\uc77c\ud074\ub860 \ud56d\uccb4<\/li>\n<li class=\"toc-level-3\">5.3.3 RNA \uae30\ubc18 \uce58\ub8cc\uc81c<\/li>\n<li class=\"toc-level-3\">5.3.4 \uae30\ud0c0<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.4 \ud22c\uc5ec \uacbd\ub85c\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.4.1 \uacbd\uad6c<\/li>\n<li class=\"toc-level-3\">5.4.2 \ube44\uacbd\uad6c (\uc815\ub9e5\/\ud53c\ud558)<\/li>\n<li class=\"toc-level-3\">5.4.3 \uacbd\ud53c\/\ube44\uac15<\/li>\n<li class=\"toc-level-3\">5.4.4 \uc218\ub9c9\uac15\ub0b4 \ud22c\uc5ec<\/li>\n<li class=\"toc-level-3\">5.4.5 \uc9d1\uc911 \ucd08\uc74c\ud30c \ub9e4\uac1c \uc804\ub2ec<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.5 \uc720\ud1b5 \ucc44\ub110\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.5.1 \ubcd1\uc6d0 \uc57d\uad6d<\/li>\n<li class=\"toc-level-3\">5.5.2 \uc18c\ub9e4 \ubc0f \uc804\ubb38 \uc57d\uad6d<\/li>\n<li class=\"toc-level-3\">5.5.3 \uc628\ub77c\uc778 \uc57d\uad6d<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.6 \uc9c0\uc5ed\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.6.1 \ubd81\ubbf8<\/li>\n<li class=\"toc-level-4\">5.6.1.1 \ubbf8\uad6d<\/li>\n<li class=\"toc-level-4\">5.6.1.2 \uce90\ub098\ub2e4<\/li>\n<li class=\"toc-level-4\">5.6.1.3 \uba55\uc2dc\ucf54<\/li>\n<li class=\"toc-level-3\">5.6.2 \uc720\ub7fd<\/li>\n<li class=\"toc-level-4\">5.6.2.1 \ub3c5\uc77c<\/li>\n<li class=\"toc-level-4\">5.6.2.2 \uc601\uad6d<\/li>\n<li class=\"toc-level-4\">5.6.2.3 \ud504\ub791\uc2a4<\/li>\n<li class=\"toc-level-4\">5.6.2.4 \uc774\ud0c8\ub9ac\uc544<\/li>\n<li class=\"toc-level-4\">5.6.2.5 \uc2a4\ud398\uc778<\/li>\n<li class=\"toc-level-4\">5.6.2.6 \uae30\ud0c0 \uc720\ub7fd<\/li>\n<li class=\"toc-level-3\">5.6.3 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-4\">5.6.3.1 \uc911\uad6d<\/li>\n<li class=\"toc-level-4\">5.6.3.2 \uc778\ub3c4<\/li>\n<li class=\"toc-level-4\">5.6.3.3 \uc77c\ubcf8<\/li>\n<li class=\"toc-level-4\">5.6.3.4 \ud638\uc8fc<\/li>\n<li class=\"toc-level-4\">5.6.3.5 \ub300\ud55c\ubbfc\uad6d<\/li>\n<li class=\"toc-level-4\">5.6.3.6 \uae30\ud0c0 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-3\">5.6.4 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.6.4.1 GCC<\/li>\n<li class=\"toc-level-4\">5.6.4.2 \ub0a8\uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.6.4.3 \uae30\ud0c0 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-3\">5.6.5 \ub0a8\ubbf8<\/li>\n<li class=\"toc-level-4\">5.6.5.1 \ube0c\ub77c\uc9c8<\/li>\n<li class=\"toc-level-4\">5.6.5.2 \uc544\ub974\ud5e8\ud2f0\ub098<\/li>\n<li class=\"toc-level-4\">5.6.5.3 \uae30\ud0c0 \ub0a8\ubbf8<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">6. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">6.1 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4<\/li>\n<li class=\"toc-level-2\">6.2 \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d<\/li>\n<li class=\"toc-level-2\">6.3 \uae30\uc5c5 \ud504\ub85c\ud544 (\uae00\ub85c\ubc8c \uac1c\uc694, \uc2dc\uc7a5 \uac1c\uc694, \ud575\uc2ec \ubd80\ubb38, \uc7ac\ubb34 \uc815\ubcf4(\uc0ac\uc6a9 \uac00\ub2a5\ud55c \uacbd\uc6b0), \uc804\ub7b5 \uc815\ubcf4, \uc8fc\uc694 \uae30\uc5c5\uc758 \uc2dc\uc7a5 \uc21c\uc704\/\uc810\uc720\uc728, \uc81c\ud488 \ubc0f \uc11c\ube44\uc2a4, \ucd5c\uadfc \uac1c\ubc1c \ud3ec\ud568)\n<ul>\n<li class=\"toc-level-3\">6.3.1 AbbVie Inc<\/li>\n<li class=\"toc-level-3\">6.3.2 AC Immune SA<\/li>\n<li class=\"toc-level-3\">6.3.3 Alector, Inc.<\/li>\n<li class=\"toc-level-3\">6.3.4 Amneal Pharmaceuticals, Inc.<\/li>\n<li class=\"toc-level-3\">6.3.5 Annovis Bio<\/li>\n<li class=\"toc-level-3\">6.3.6 Athira Pharma<\/li>\n<li class=\"toc-level-3\">6.3.7 Biogen Inc.<\/li>\n<li class=\"toc-level-3\">6.3.8 Biohaven Pharmaceuticals<\/li>\n<li class=\"toc-level-3\">6.3.9 Boehringer Ingelheim International GmbH<\/li>\n<li class=\"toc-level-3\">6.3.10 Denali Therapeutics Inc.<\/li>\n<li class=\"toc-level-3\">6.3.11 Eisai Co., Ltd.<\/li>\n<li class=\"toc-level-3\">6.3.12 Eli Lilly and Company<\/li>\n<li class=\"toc-level-3\">6.3.13 F. Hoffmann-La Roche AG<\/li>\n<li class=\"toc-level-3\">6.3.14 H. Lundbeck A\/S<\/li>\n<li class=\"toc-level-3\">6.3.15 Ionis Pharmaceuticals, Inc.<\/li>\n<li class=\"toc-level-3\">6.3.16 Johnson &amp; Johnson Services, Inc. (Janssen)<\/li>\n<li class=\"toc-level-3\">6.3.17 Merck &amp; Co.<\/li>\n<li class=\"toc-level-3\">6.3.18 Neuron23 Inc.<\/li>\n<li class=\"toc-level-3\">6.3.19 Novartis Inc<\/li>\n<li class=\"toc-level-3\">6.3.20 Oryzon Genomics<\/li>\n<li class=\"toc-level-3\">6.3.21 Pfizer Inc.<\/li>\n<li class=\"toc-level-3\">6.3.22 Prothena<\/li>\n<li class=\"toc-level-3\">6.3.23 Revance Therapeutics, Inc.<\/li>\n<li class=\"toc-level-3\">6.3.24 Sanofi<\/li>\n<li class=\"toc-level-3\">6.3.25 Seelos Therapeutics<\/li>\n<li class=\"toc-level-3\">6.3.26 Solid Biosciences Inc.<\/li>\n<li class=\"toc-level-3\">6.3.27 Teva Pharmaceutical Industries Ltd.<\/li>\n<li class=\"toc-level-3\">6.3.28 UCB<\/li>\n<li class=\"toc-level-3\">6.3.29 Vertex Pharmaceuticals Incorporated<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-6\">7. \uc2dc\uc7a5 \uae30\ud68c \ubc0f \ubbf8\ub798 \uc804\ub9dd<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\uc2e0\uacbd\ud1f4\ud589\uc131 \uc9c8\ud658 \uc2dc\uc7a5 \ubd84\uc11d: \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f 2026-2031\ub144 \uc608\uce21<\/p>\n<p># 1. \uc2dc\uc7a5 \uac1c\uc694 \ubc0f \uc804\ub9dd<\/p>\n<p>\uc2e0\uacbd\ud1f4\ud589\uc131 \uc9c8\ud658 \uc2dc\uc7a5\uc740 2025\ub144 590\uc5b5 6\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0\uc11c 2026\ub144 632\uc5b5 1\ucc9c\ub9cc \ub2ec\ub7ec\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub418\uba70, 2031\ub144\uc5d0\ub294 888\uc5b5 3\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0 \ub2ec\ud558\uc5ec 2026\ub144\ubd80\ud130 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR) 7.04%\ub97c \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uacac\uace0\ud55c \uc131\uc7a5\uc740 \uc804 \uc138\uacc4\uc801\uc778 \uace0\ub839\ud654 \uc778\uad6c \uc99d\uac00, \uc9c8\ubcd1 \uc870\uc808 \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c\uc758 \uc0c8\ub85c\uc6b4 \uc2b9\uc778, \uadf8\ub9ac\uace0 \uc870\uae30 \uac1c\uc785\uc744 \uac00\ub2a5\ud558\uac8c \ud558\ub294 \uc815\ubc00 \uc9c4\ub2e8 \ub3c4\uad6c\uc758 \ubc1c\uc804\uc774 \uc8fc\uc694 \ub3d9\uc778\uc73c\ub85c \uc791\uc6a9\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uacbd\uc7c1 \ud658\uacbd\uc740 \uae30\uc874 \ube14\ub85d\ubc84\uc2a4\ud130 \uc81c\ud488\uc744 \ubc29\uc5b4\ud558\ub824\ub294 \uae30\uc874 \uae30\uc5c5\ub4e4\uacfc \uc720\uc804\uc790 \ubc0f RNA \uce58\ub8cc\uc81c\ub97c \ud6c4\uae30 \uc784\uc0c1 \ub2e8\uacc4\ub85c \ucd94\uc9c4\ud558\ub294 \ubc14\uc774\uc624\uae30\uc220 \uc2e0\uaddc \uae30\uc5c5\ub4e4 \uac04\uc758 \uacbd\uc7c1 \uc2ec\ud654\ub85c \ud2b9\uc9d5\uc9c0\uc5b4\uc9d1\ub2c8\ub2e4. \ubbf8\uad6d\uc5d0\uc11c\ub294 \uace0\uac00 \uce58\ub8cc\uc81c\uc5d0 \ub300\ud55c \uc9c0\ubd88 \uc758\uc9c0\uac00 \uc5ec\uc804\ud788 \ub192\uc9c0\ub9cc, \uc99d\uc0c1 \uc644\ud654 \uc57d\ubb3c\uc758 \uc81c\ub124\ub9ad \uce68\uc2dd\uc740 \ub9e4\ucd9c \uad6c\uc131\uc744 \ubcc0\ud654\uc2dc\ud0a4\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed \uc815\ubd80\uc758 \uc804\uad6d\uc801\uc778 \uce58\ub9e4 \uac80\uc9c4 \uc758\ubb34\ud654\ub294 \uc9c4\ub2e8 \uac80\uc0ac\ub7c9 \uc99d\uac00\uc640 \uc2dc\uc57d \uc218\uc694\ub97c \ucd09\uc9c4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. AI \uae30\ubc18 \uc2e0\uc57d \ubc1c\uad74 \ud50c\ub7ab\ud3fc\uc740 \ud45c\uc801 \uc2dd\ubcc4 \uc2dc\uac04\uc744 \ub2e8\ucd95\ud558\uace0 \ubca4\ucc98 \uce90\ud53c\ud0c8\uc744 \uc720\uc804\uc801\uc73c\ub85c \uc815\uc758\ub41c \ud2c8\uc0c8 \uc801\uc751\uc99d\uc73c\ub85c \uc720\uc778\ud558\uba70 \uacbd\uc7c1 \uac15\ub3c4\ub97c \ub192\uc774\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\ubcf8 \ubcf4\uace0\uc11c\uc5d0 \ub530\ub974\uba74, \uc5f0\uad6c \uae30\uac04\uc740 2020\ub144\ubd80\ud130 2031\ub144\uae4c\uc9c0\uc774\uba70, \uc2dc\uc7a5 \uaddc\ubaa8\ub294 2026\ub144 632\uc5b5 1\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0\uc11c 2031\ub144 888\uc5b5 3\ucc9c\ub9cc \ub2ec\ub7ec\ub85c \uc5f0\ud3c9\uade0 7.04%\uc758 \uc131\uc7a5\ub960\uc744 \ubcf4\uc77c \uac83\uc73c\ub85c \uc608\uce21\ub429\ub2c8\ub2e4. \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \uc2dc\uc7a5\uc740 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc774\uba70, \uac00\uc7a5 \ud070 \uc2dc\uc7a5\uc740 \ubd81\ubbf8 \uc9c0\uc5ed\uc785\ub2c8\ub2e4. \uc2dc\uc7a5 \uc9d1\uc911\ub3c4\ub294 &#8216;\uc911\uac04&#8217; \uc218\uc900\uc73c\ub85c \ud3c9\uac00\ub429\ub2c8\ub2e4.<\/p>\n<p># 2. \ud575\uc2ec \ubcf4\uace0\uc11c \uc694\uc57d (Key Report Takeaways)<\/p>\n<p>*   \uc801\uc751\uc99d\ubcc4: 2025\ub144 \uc54c\uce20\ud558\uc774\uba38\ubcd1\uc774 \uc2e0\uacbd\ud1f4\ud589\uc131 \uc9c8\ud658 \uc2dc\uc7a5 \uc810\uc720\uc728\uc758 41.72%\ub97c \ucc28\uc9c0\ud588\uc73c\uba70, \uadfc\uc704\ucd95\uc131 \uce21\uc0ad \uacbd\ud654\uc99d(ALS)\uc740 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 9.36%\uc758 \uc131\uc7a5\ub960\uc744 \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<br \/>\n*   \uc57d\ubb3c \ubd84\ub958\ubcc4: 2025\ub144 \ucf5c\ub9b0\uc5d0\uc2a4\ud14c\ub77c\uc81c \uc5b5\uc81c\uc81c\uac00 \uc2dc\uc7a5 \uc810\uc720\uc728\uc758 27.98%\ub97c \ucc28\uc9c0\ud588\uc73c\uba70, \uc720\uc804\uc790 \ubc0f \uc138\ud3ec \uce58\ub8cc\uc81c\ub294 2026\ub144\ubd80\ud130 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 9.21% \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<br \/>\n*   \ubd84\uc790 \uc720\ud615\ubcc4: 2025\ub144 \uc800\ubd84\uc790 \uc57d\ubb3c\uc774 60.55%\uc758 \uc810\uc720\uc728\ub85c \uc6b0\uc704\ub97c \uc810\ud588\uc73c\uba70, RNA \uae30\ubc18 \uce58\ub8cc\uc81c\ub294 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 9.14%\ub85c \uac00\uc7a5 \ube60\ub978 \uc131\uc7a5\uc744 \ubcf4\uc77c \uac83\uc73c\ub85c \uc608\uce21\ub429\ub2c8\ub2e4.<br \/>\n*   \ud22c\uc5ec \uacbd\ub85c\ubcc4: 2025\ub144 \uacbd\uad6c \ud22c\uc5ec\uac00 76.88%\uc758 \uc810\uc720\uc728\ub85c \uc9c0\ubc30\uc801\uc774\uc5c8\uc73c\uba70, \uacbd\ud53c \ub610\ub294 \ube44\uac15 \ud22c\uc5ec\ub294 \uac19\uc740 \uae30\uac04 \ub3d9\uc548 \uc5f0\ud3c9\uade0 9.88% \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<br \/>\n*   \uc720\ud1b5 \ucc44\ub110\ubcc4: 2025\ub144 \ubcd1\uc6d0 \uc57d\uad6d\uc774 53.92%\uc758 \uc810\uc720\uc728\ub85c \uc120\ub450\ub97c \ub2ec\ub838\uc73c\uba70, \uc628\ub77c\uc778 \uc57d\uad6d\uc740 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 10.08% \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<br \/>\n*   \uc9c0\uc5ed\ubcc4: 2025\ub144 \ubd81\ubbf8\uac00 \uc804\uccb4 \ub9e4\ucd9c\uc758 41.96%\ub97c \ucc28\uc9c0\ud588\uc73c\uba70, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc740 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 8.31%\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<\/p>\n<p># 3. \uc2dc\uc7a5 \ub3d9\ud5a5 \ubc0f \ud1b5\ucc30 (Market Trends and Insights)<\/p>\n<p> 3.1. \uc131\uc7a5 \ub3d9\uc778 (Drivers)<\/p>\n<p>*   \uace0\ub839\ud654 \uc778\uad6c \uc99d\uac00\ub85c \uc778\ud55c \uc9c8\ubcd1 \ubd80\ub2f4 \uc2ec\ud654: 2030\ub144\uae4c\uc9c0 65\uc138 \uc774\uc0c1 \uc778\uad6c\uac00 \uc804 \uc138\uacc4 \uc778\uad6c\uc758 16.5%\ub97c \ucc28\uc9c0\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub418\uba70, \uc77c\ubcf8\uc740 \uc774\ubbf8 2024\ub144\uc5d0 29.1%\uc5d0 \ub2ec\ud588\uc2b5\ub2c8\ub2e4. \uc774\uc5d0 \ub530\ub77c \uac01\uad6d \uc815\ubd80\ub294 \uc9c0\uc5ed\uc0ac\ud68c \uac80\uc9c4 \uc758\ubb34\ud654\ub97c \ucd94\uc9c4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc77c\ubcf8\uc740 2025\ub144 4\uc6d4\ubd80\ud130 75\uc138 \uc774\uc0c1 \uc2dc\ubbfc\uc5d0\uac8c \uc758\ubb34\uc801\uc778 \uc5f0\uac04 \uc778\uc9c0 \uac80\uc0ac\ub97c \uc2dc\uc791\ud588\uc73c\uba70, \ud55c\uad6d\ub3c4 2026\ub144 1\uc6d4 \uc720\uc0ac\ud55c \ud504\ub85c\uadf8\ub7a8\uc744 \uc2dc\ud589\ud588\uc2b5\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uc815\ucc45\uc740 \uc870\uae30 \uc9c4\ub2e8 \ubc0f \uac1c\uc785\uc5d0 \ub300\ud55c \uc9c0\ubd88 \uc758\uc9c0\ub97c \ub192\uc774\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc9c8\ubcd1 \uc870\uc808 \uce58\ub8cc\uc81c\uc758 \ucd9c\uc2dc \ubc0f \ubcf4\ud5d8 \uc801\uc6a9 \ud655\ub300: 2024\ub144 \ub3c4\ub098\ub124\ub9d9(donanemab)\uacfc \ud53c\ud558 \uc8fc\uc0ac\ud615 \ub808\uce74\ub124\ub9d9(lecanemab)\uc758 \uc2b9\uc778\uc740 \uc99d\uc0c1 \uc644\ud654\uc5d0\uc11c \uc9c8\ubcd1 \uc870\uc808\ub85c \uce58\ub8cc \ud328\ub7ec\ub2e4\uc784\uc744 \uc804\ud658\uc2dc\ucf30\uc2b5\ub2c8\ub2e4. \uc774\ub4e4\uc758 \ucd9c\uc2dc\ub294 \uc544\ubc00\ub85c\uc774\ub4dc \ud50c\ub77c\ud06c \uc81c\uac70 \ubc0f \uc778\uc9c0 \uc548\uc815\ud654 \ud6a8\uacfc\uac00 \uc785\uc99d\ub420 \uacbd\uc6b0 \uace0\uac00 \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c\uc5d0 \ub300\ud55c \ubcf4\ud5d8 \uc801\uc6a9\uc774 \uac00\ub2a5\ud558\ub2e4\ub294 \uac83\uc744 \ubcf4\uc5ec\uc8fc\uc5c8\uc2b5\ub2c8\ub2e4. 15\uac1c \uc774\uc0c1\uc758 \ud56d\uc544\ubc00\ub85c\uc774\ub4dc \ub610\ub294 \ud56d\ud0c0\uc6b0 \ud56d\uccb4\uac00 3\uc0c1 \ud30c\uc774\ud504\ub77c\uc778\uc5d0 \uc788\uc73c\uba70, \uc774\ub294 \uce58\ub8cc\uc81c \uac1c\ubc1c \uacbd\uc7c1\uc744 \uc608\uace0\ud569\ub2c8\ub2e4.<br \/>\n*   \uc2e0\uacbd \uc601\uc0c1 \ubc0f \ud608\uc561 \uae30\ubc18 \ubc14\uc774\uc624\ub9c8\ucee4 \uc9c4\ub2e8\uc758 \ubc1c\uc804: \uc815\ubc00 \uc9c4\ub2e8\uc740 \uac1c\uc778 \ub9de\ucda4\ud615 \uce58\ub8cc \uc54c\uace0\ub9ac\uc998\uc758 \uae30\ubc18\uc774 \ub429\ub2c8\ub2e4. \uc544\ubc00\ub85c\uc774\ub4dc PET, \ub1cc\ucc99\uc218\uc561(CSF) p-tau \ubd84\uc11d, \uadf8\ub9ac\uace0 \uc0c8\ub85c\uc6b4 \ud608\uc561 \uae30\ubc18 \uac80\uc0ac\ub294 \uc804\uc784\uc0c1 \ub2e8\uacc4 \ud658\uc790 \ubd84\ub958\ub97c \uac00\ub2a5\ud558\uac8c \ud558\uc5ec \uc784\uc0c1 \uc2dc\ud5d8 \uc131\uacf5\ub960\uc744 \ub192\uc774\uace0 \uc870\uae30 \ucc98\ubc29\uc744 \uc6a9\uc774\ud558\uac8c \ud569\ub2c8\ub2e4. \ub780\ud14c\uc6b0\uc2a4(Lantheus)\uc758 2024\ub144 \ub77c\uc774\ud504 \ubd84\uc790 \uc601\uc0c1(Life Molecular Imaging) \uc778\uc218\ub294 \uc0c1\uc5c5\uc801 \uce58\ub8cc \uacbd\ub85c\uc5d0 \ud1b5\ud569\ub420 \ub3c5\uc810 \ucd94\uc801\uc790\ub97c \ud655\ubcf4\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc2e0\uacbd\uacfc\ud559 R&#038;D \ud22c\uc790 \ud655\ub300: \ub85c\uc288(Roche)\uc758 2030\ub144\uae4c\uc9c0 500\uc5b5 \ub2ec\ub7ec \ud22c\uc790 \uc57d\uc18d\uc740 \uc774 \ubd84\uc57c\uc758 \ub9c9\ub300\ud55c \uc790\ubcf8 \uc720\uc785\uc744 \ubcf4\uc5ec\uc90d\ub2c8\ub2e4. \uc77c\ub77c\uc774 \ub9b4\ub9ac(Eli Lilly), \ub178\ubc14\ud2f0\uc2a4(Novartis), \ub2e4\ucf00\ub2e4(Takeda) \ub4f1\ub3c4 \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c \uc81c\uc870 \ubc0f AI \uae30\ubc18 \ud45c\uc801 \ubc1c\uad74\uc5d0 \uc9d1\uc911\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ubca4\ucc98 \uce90\ud53c\ud0c8 \uc790\uae08\uc740 \ub2e8\ubc31\uc9c8 \ubd84\ud574\uc81c \ubc0f \uc720\uc804\uc790 \ud3b8\uc9d1 \ubc29\uc2dd\uacfc \uac19\uc740 \ud50c\ub7ab\ud3fc \uae30\uc220\uc5d0 \uc911\uc810\uc744 \ub450\uba70 \ud68c\ubcf5\uc138\ub97c \ubcf4\uc774\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   AI \uae30\ubc18 \uc2e0\uaddc \ud45c\uc801 \ubc1c\uad74: AI \uae30\ubc18 \uc2e0\uc57d \ubc1c\uad74 \ud50c\ub7ab\ud3fc\uc740 \ud45c\uc801 \uc2dd\ubcc4 \uc2dc\uac04\uc744 \ub2e8\ucd95\ud558\uace0 \ubca4\ucc98 \uce90\ud53c\ud0c8\uc744 \uc720\uc804\uc801\uc73c\ub85c \uc815\uc758\ub41c \ud2c8\uc0c8 \uc801\uc751\uc99d\uc73c\ub85c \uc720\uc778\ud558\uba70 \uacbd\uc7c1 \uac15\ub3c4\ub97c \ub192\uc774\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \ub1cc \ud45c\uc801 \uc57d\ubb3c \uc804\ub2ec \ud50c\ub7ab\ud3fc: \ub1cc \ud45c\uc801 \uc57d\ubb3c \uc804\ub2ec \ud50c\ub7ab\ud3fc\uc758 \ubc1c\uc804\uc740 \uce58\ub8cc \ud6a8\uacfc\ub97c \ub192\uc774\ub294 \ub370 \uae30\uc5ec\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p> 3.2. \uc2dc\uc7a5 \uc81c\uc57d \uc694\uc778 (Restraints)<\/p>\n<p>*   \ud6c4\uae30 \uc784\uc0c1 \uc2dc\ud5d8\uc758 \ub192\uc740 \uc2e4\ud328\uc728: \uc77c\ub77c\uc774 \ub9b4\ub9ac\ub294 2024\ub144 12\uc6d4 \uc778\uc9c0 \ud3c9\uac00 \uc9c0\ud45c \ubbf8\ub2ec\ub85c \uc790\uace0\ud14c\ub124\ub9d9(zagotenemab) \uac1c\ubc1c\uc744 \uc911\ub2e8\ud558\uba70 12\uc5b5 \ub2ec\ub7ec\ub97c \uc0c1\uac01\ud588\uc2b5\ub2c8\ub2e4. \ub85c\uc288\ub294 2024\ub144 3\uc6d4 \uac04\ud14c\ub124\ub8e8\ub9d9(gantenerumab) \uc54c\uce20\ud558\uc774\uba38 \uc608\ubc29 \uc5f0\uad6c\ub97c \ubb34\uc775\ud558\ub2e4\ub294 \uc774\uc720\ub85c \uc885\ub8cc\ud588\uc2b5\ub2c8\ub2e4. \uaddc\uc81c \ub2f9\uad6d\uc740 \ub300\ub9ac \ud3c9\uac00 \uc9c0\ud45c\ub97c \ud5c8\uc6a9\ud558\uc9c0\ub9cc, \ud655\uc99d \uc784\uc0c1 \uc2dc\ud5d8\uc740 9\ub144 \uc774\ub0b4\uc5d0 \uc784\uc0c1\uc801 \uc774\uc810\uc744 \uc785\uc99d\ud574\uc57c \ud558\ubbc0\ub85c \uc0c1\uc5c5\ud654 \uae30\uac04\uc774 \ub2e8\ucd95\ub429\ub2c8\ub2e4.<br \/>\n*   \ucca8\ub2e8 \uce58\ub8cc\uc81c\uc758 \ub192\uc740 \uac00\uaca9: \ub808\uce74\ub124\ub9d9\uc740 \uc5f0\uac04 26,500\ub2ec\ub7ec, \ub3c4\ub098\ub124\ub9d9\uc740 \uc57d 32,000\ub2ec\ub7ec\ub85c \uc608\uc0c1\ub418\uc5b4 \uba54\ub514\ucf00\uc5b4 \ud30c\ud2b8 B \uc9c0\ucd9c\uc744 \ud06c\uac8c \uc99d\uac00\uc2dc\ud0ac \uc218 \uc788\uc2b5\ub2c8\ub2e4. \ub178\ubc14\ud2f0\uc2a4(Novartis)\uc758 \uc878\uac90\uc2a4\ub9c8(Zolgensma)\ub294 \ud658\uc790\ub2f9 210\ub9cc \ub2ec\ub7ec\uc5d0 \ub2ec\ud558\uba70, \uc131\uacfc \uae30\ubc18 \uacc4\uc57d\uc740 \uc6b4\ub3d9 \uc774\uc815\ud45c\uc5d0 \ub530\ub77c \uc9c0\ubd88\uc561\uc744 \uc5f0\ub3d9\ud569\ub2c8\ub2e4.<br \/>\n*   \uc81c\ud55c\uc801\uc778 \ubc14\uc774\uc624\ub9c8\ucee4 \uc778\ud504\ub77c: \ub77c\ud2f4 \uc544\uba54\ub9ac\uce74, \uc911\ub3d9, \uc544\ud504\ub9ac\uce74, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591\uc758 \ub18d\ucd0c \uc9c0\uc5ed\uc5d0\uc11c\ub294 \ubc14\uc774\uc624\ub9c8\ucee4 \uc778\ud504\ub77c\uac00 \uc81c\ud55c\uc801\uc774\ub77c\ub294 \uc810\uc774 \uc7a5\uae30\uc801\uc778 \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc800\ud574\ud560 \uc218 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130 \uc81c\uc870 \ubcd1\ubaa9 \ud604\uc0c1: \ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130 \uc81c\uc870\uc758 \ubcd1\ubaa9 \ud604\uc0c1\uc740 \ubd81\ubbf8, \uc720\ub7fd, \uc77c\ubcf8 \ub4f1\uc9c0\uc5d0\uc11c \uc2e0\uc57d \ucd9c\uc2dc\ub97c \uc9c0\uc5f0\uc2dc\ud0ac \uc218 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc8fc\uc694 \uc2e0\uacbd\ud559 \ube0c\ub79c\ub4dc\uc758 \ud2b9\ud5c8 \ub9cc\ub8cc: 2026\ub144 \uc544\ub9ac\uc149\ud2b8(Aricept)\uc758 \ud2b9\ud5c8 \ub9cc\ub8cc\ub294 28\uc5b5 \ub2ec\ub7ec\uc758 \ube0c\ub79c\ub4dc \ub9e4\ucd9c\uc744 \uc18c\uba78\uc2dc\ud0a4\uace0 \uc81c\ub124\ub9ad \ub3c4\ub124\ud398\uc9c8(donepezil) \uacbd\uc7c1\uc790\ub4e4 \uac04\uc758 \uac00\uaca9 \uacbd\uc7c1\uc744 \uc720\ubc1c\ud560 \uac83\uc785\ub2c8\ub2e4. 2029\ub144\uc5d0\ub294 \ub0a8\uc790\ub9ac\ud06c(Namzaric)\ub3c4 \uc720\uc0ac\ud55c \uce68\uc2dd\uc744 \uacaa\uc744 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc774\ub294 \ub2e8\uae30\uc801\uc778 \ub9e4\ucd9c \uc131\uc7a5\uc744 \uc5b5\uc81c\ud558\uc9c0\ub9cc, \uae30\uc5c5\ub4e4\uc774 \uace0\ubd80\uac00\uac00\uce58 \ud601\uc2e0\uc744 \uac00\uc18d\ud654\ud558\ub3c4\ub85d \uc720\ub3c4\ud558\uc5ec \uad81\uadf9\uc801\uc73c\ub85c \uc2e0\uacbd\ud1f4\ud589\uc131 \uc9c8\ud658 \uc2dc\uc7a5\uc744 \uc9c0\uc18d \uac00\ub2a5\ud558\uac8c \ud569\ub2c8\ub2e4.<\/p>\n<p># 4. \uc138\uadf8\uba3c\ud2b8 \ubd84\uc11d (Segment Analysis)<\/p>\n<p> 4.1. \uc801\uc751\uc99d\ubcc4: \uc54c\uce20\ud558\uc774\uba38\ubcd1 \uc9c0\ubc30, ALS \uc131\uc7a5 (By Indication: Alzheimer\u2019s Disease Dominates Despite ALS Growth)<br \/>\n\uc54c\uce20\ud558\uc774\uba38\ubcd1\uc740 \ub192\uc740 \uc720\ubcd1\ub960\uacfc \ub2e4\uc591\ud55c \uce58\ub8cc\uc81c\ub85c \uc778\ud574 2025\ub144 \uc2e0\uacbd\ud1f4\ud589\uc131 \uc9c8\ud658 \uc2dc\uc7a5 \uc810\uc720\uc728\uc758 41.72%\ub97c \ucc28\uc9c0\ud588\uc2b5\ub2c8\ub2e4. 2025\ub144 \ub808\ucf10\ube44(Leqembi) \ub9e4\ucd9c \uae09\uc99d\uc740 \uc9c8\ubcd1 \uc870\uc808 \ud56d\uccb4\uc758 \uc0c1\uc5c5\uc801 \uc7a0\uc7ac\ub825\uc744 \uc7ac\ud655\uc778\ud588\uc2b5\ub2c8\ub2e4. \ud30c\ud0a8\uc2a8\ubcd1\uacfc \ub2e4\ubc1c\uc131 \uacbd\ud654\uc99d\uc740 \ub3c4\ud30c\ubbfc\uc131 \ubc0f \uba74\uc5ed \uc870\uc808 \uc694\ubc95\uc744 \ud1b5\ud574 \uafb8\uc900\ud55c \uc218\uc694\ub97c \uc720\uc9c0\ud558\uc9c0\ub9cc, \ud601\uc2e0 \uc18d\ub3c4\ub294 \ub354\ub525\ub2c8\ub2e4. ALS\ub294 \ube44\ub85d \uc2dc\uc7a5 \uaddc\ubaa8\ub294 \uc791\uc9c0\ub9cc, \uc720\uc804\uc790 \uce68\ubb35 \ud6c4\ubcf4 \ubb3c\uc9c8\uacfc \uc2e0\uc0dd\uc544 \uac80\uc9c4 \ud504\ub85c\uadf8\ub7a8 \ud655\ub300\ub85c \uc5f0\ud3c9\uade0 9.36%\uc758 \uc131\uc7a5\ub960\uc744 \ubcf4\uc774\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ud5cc\ud305\ud134\ubcd1\uc740 \ud504\ub9ac\ub3c4\ud53c\ub518(Pridopidine)\uc758 \uc720\ub7fd \uc2b9\uc778\uc73c\ub85c \ucc98\uc74c\uc73c\ub85c \uc2e4\uc9c8\uc801\uc778 \uc9c8\ubcd1 \uc870\uc808 \uc635\uc158\uc744 \uc5bb\uc5c8\uc2b5\ub2c8\ub2e4.<\/p>\n<p> 4.2. \uc57d\ubb3c \ubd84\ub958\ubcc4: \ucf5c\ub9b0\uc5d0\uc2a4\ud14c\ub77c\uc81c \uc5b5\uc81c\uc81c \uc8fc\ub3c4, \uc720\uc804\uc790 \uce58\ub8cc\uc81c \ubd80\uc0c1 (By Drug Class: Cholinesterase Inhibitors Anchor, Gene Therapies Ascend)<br \/>\n\ucf5c\ub9b0\uc5d0\uc2a4\ud14c\ub77c\uc81c \uc5b5\uc81c\uc81c\ub294 \uae30\uc874\uc758 1\ucc28 \uce58\ub8cc\uc81c \uc0ac\uc6a9\uc744 \ubc18\uc601\ud558\uc5ec 2025\ub144 \uc2e0\uacbd\ud1f4\ud589\uc131 \uc9c8\ud658 \uc2dc\uc7a5\uc758 27.98%\ub97c \ucc28\uc9c0\ud588\uc2b5\ub2c8\ub2e4. \uadf8\ub7ec\ub098 \ud30c\uc774\ud504\ub77c\uc778 \uac1c\ubc1c \uc18d\ub3c4\ub294 \uc720\uc804\uc790 \ubc0f \uc138\ud3ec \uce58\ub8cc\uc81c\uc5d0 \uc720\ub9ac\ud558\uac8c \uc791\uc6a9\ud558\uace0 \uc788\uc73c\uba70, \ubca1\ud130 \uc124\uacc4 \ubc0f \uc81c\uc870 \uaddc\ubaa8 \uac1c\uc120\uc5d0 \ub530\ub77c \uc5f0\uac04 9.21% \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \ubaa8\ub178\ud074\ub85c\ub0a0 \ud56d\uccb4\ub294 \uc544\ubc00\ub85c\uc774\ub4dc\ub97c \ub118\uc5b4 \uc54c\ud30c-\uc2dc\ub204\ud074\ub808\uc778(alpha-synuclein) \ubc0f TDP-43\uc744 \ud45c\uc801\uc73c\ub85c \ud655\uc7a5\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4. NMDA \uae38\ud56d\uc81c\uc640 \ub3c4\ud30c\ubbfc \uc791\uc6a9\uc81c\ub294 \uc5ec\uc804\ud788 \uc8fc\uc694 \uc57d\ubb3c\uc774\uc9c0\ub9cc \uc81c\ub124\ub9ad \uacbd\uc7c1\uc5d0 \uc9c1\uba74\ud574 \uc788\uc2b5\ub2c8\ub2e4. RNA \uce58\ub8cc\uc81c\ub294 \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c\ubcf4\ub2e4 \ub0ae\uc740 \uc81c\uc870\uc6d0\uac00\uc640 \uc800\ubd84\uc790 \uc57d\ubb3c\ubcf4\ub2e4 \ub192\uc740 \ud2b9\uc774\uc131\uc744 \ubc14\ud0d5\uc73c\ub85c \uc804\ub7b5\uc801\uc778 \uc911\uac04 \uc9c0\uc810\uc744 \ucc28\uc9c0\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p> 4.3. \ubd84\uc790 \uc720\ud615\ubcc4: \uc800\ubd84\uc790 \uc57d\ubb3c \uc120\ub450, RNA \uce58\ub8cc\uc81c \uc131\uc7a5 (By Molecule Type: Small Molecules Lead, RNA Therapeutics Gain Traction)<br \/>\n\uc800\ubd84\uc790 \uc57d\ubb3c\uc740 \uacbd\uad6c \ud22c\uc5ec \uc120\ud638\ub3c4\uc640 \uc131\uc219\ud55c \uacf5\uae09\ub9dd\uc5d0 \ud798\uc785\uc5b4 2025\ub144 60.55%\uc758 \uc810\uc720\uc728\uc744 \uc720\uc9c0\ud588\uc2b5\ub2c8\ub2e4. \uadf8\ub7ec\ub098 \uc548\ud2f0\uc13c\uc2a4 \uc62c\ub9ac\uace0\ub274\ud074\ub808\uc624\ud0c0\uc774\ub4dc(antisense oligonucleotides) \ubc0f siRNA \ud50c\ub7ab\ud3fc\uc740 \uc5f0\ud3c9\uade0 9.14%\uc758 \uc131\uc7a5\ub960\uc744 \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc608\uce21\ub418\uba70, \ud22c\uc5ec \uac04\uaca9\uc744 \ubd84\uae30\ubcc4 \ub610\ub294 \ubc18\uae30\ubcc4\ub85c \uc5f0\uc7a5\ud558\ub294 \ud654\ud559\uc801 \ubcc0\ud615\uc758 \uc774\uc810\uc744 \ub204\ub9ac\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c(\uc774\uc911\ud2b9\uc774\uc131 \ud56d\uccb4 \ud3ec\ud568)\ub294 \uc8fc\uc785 \uc2dc\uac04\uc744 \ub2e8\ucd95\ud558\uace0 \uce58\ub8cc \ube44\uc6a9\uc744 \uc808\uac10\ud558\ub294 \ud53c\ud558 \uc81c\ud615\uc744 \ud1b5\ud574 \ud655\uc7a5\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p> 4.4. \ud22c\uc5ec \uacbd\ub85c\ubcc4: \uc0c8\ub85c\uc6b4 \uc804\ub2ec \ubc29\uc2dd \uc131\uc7a5 (By Route of Administration: Novel Delivery Gains Traction)<br \/>\n\uacbd\uad6c \ud22c\uc5ec\ub294 2025\ub144 76.88%\uc758 \uc810\uc720\uc728\ub85c \uc9c0\ubc30\uc801\uc774\uc5c8\uc9c0\ub9cc, \ud658\uc790 \ubc0f \ubcf4\ud638\uc790 \uc124\ubb38\uc870\uc0ac\uc5d0 \ub530\ub974\uba74 \uc784\uc0c1\uc801 \uc774\uc810\uc774 \uc785\uc99d\ub420 \uacbd\uc6b0 \ucd5c\uc18c \uce68\uc2b5\uc801 \ub300\uc548\uc5d0 \ub300\ud55c \uc218\uc6a9\ub3c4\uac00 \ub192\uc544\uc9c0\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ube44\uac15 \uae00\ub8e8\ud0c0\ud2f0\uc628(intranasal glutathione) \ubc0f \uacbd\ud53c \ub85c\ud2f0\uace0\ud2f4(transdermal rotigotine) \uc2dc\ubc94 \ud504\ub85c\uadf8\ub7a8\uc740 \ub192\uc740 \uc21c\uc751\ub3c4\ub97c \uae30\ub85d\ud558\uba70 \uc774\ub7ec\ud55c \uacbd\ub85c\uc758 \uc5f0\ud3c9\uade0 9.88% \uc131\uc7a5\ub960 \uc608\uce21\uc744 \ub4b7\ubc1b\uce68\ud569\ub2c8\ub2e4. \uaddc\uc81c \uae30\uad00\uc740 \uc6b4\ub3d9 \uc99d\uc0c1 \ubcc0\ub3d9 \uc81c\uc5b4\uc758 \ubbf8\ucda9\uc871 \uc218\uc694\ub97c \uc778\uc2dd\ud558\uc5ec \uae30\uae30-\uc57d\ubb3c \ubcf5\ud569\uc81c \uac80\ud1a0\ub97c \uc2e0\uc18d\ud558\uac8c \ucc98\ub9ac\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p> 4.5. \uc720\ud1b5 \ucc44\ub110\ubcc4: \ub514\uc9c0\ud138 \uc804\ud658 \uac00\uc18d\ud654 (By Distribution Channel: Digital Transformation Accelerates)<br \/>\n\ubcd1\uc6d0 \uc57d\uad6d\uc740 \ud56d\uccb4 \ubc0f \uc720\uc804\uc790 \uce58\ub8cc\uc81c\uc758 \ucd08\uae30 \ud504\ub85c\ud1a0\ucf5c\uc774 \uc804\ubb38\uc758 \uac10\ub3c5\uc744 \uc694\uad6c\ud568\uc5d0 \ub530\ub77c 2025\ub144 \uc2e0\uacbd\ud1f4\ud589\uc131 \uc9c8\ud658 \uc2dc\uc7a5 \uc810\uc720\uc728\uc758 53.92%\ub97c \ucc28\uc9c0\ud588\uc2b5\ub2c8\ub2e4. \uadf8\ub7ec\ub098 \uc6d0\uaca9 \uc758\ub8cc \ud655\uc0b0\uc740 \uc628\ub77c\uc778 \uc57d\uad6d CAGR\uc744 10.08%\ub85c \ub04c\uc5b4\uc62c\ub9ac\uace0 \uc788\uc73c\uba70, \uc804\uc790 \ucc98\ubc29\uc804 \ud1b5\ud569\uc744 \ud1b5\ud574 \uc720\uc9c0 \uc6a9\ub7c9\uc5d0 \ub300\ud55c \uc9c1\uc811 \uac00\uc815 \ubc30\uc1a1\uc774 \uac00\ub2a5\ud574\uc9c0\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc804\ubb38 \uc57d\uad6d\uc740 \ucf5c\ub4dc \uccb4\uc778 \uc5ed\ub7c9\uc744 \uac15\ud654\ud558\uace0 \uac04\ud638\uc0ac \uc8fc\ub3c4 \uc21c\uc751\ub3c4 \ud504\ub85c\uadf8\ub7a8\uc744 \ubc30\ud3ec\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc18c\ub9e4 \uccb4\uc778\uc740 \ub9e4\uc7a5 \ub0b4 \uc778\uc9c0 \uac80\uc0ac\ub97c \uc704\ud55c \uc0c1\ub2f4\uc2e4\uc744 \uc5c5\uadf8\ub808\uc774\ub4dc\ud558\uc5ec \uc9c4\ub2e8\uacfc \uc870\uc81c\ub97c \uc5f0\uacb0\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p># 5. \uc9c0\uc5ed \ubd84\uc11d (Geography Analysis)<\/p>\n<p>*   \ubd81\ubbf8: 2025\ub144 \uc804 \uc138\uacc4 \ub9e4\ucd9c\uc758 41.96%\ub97c \ucc28\uc9c0\ud588\uc73c\uba70, FDA\uc758 \uc2e0\uc18d \uc2b9\uc778 \uacbd\ub85c\uc640 \uba54\ub514\ucf00\uc5b4 \ubcf4\ud5d8 \uc801\uc6a9\uc774 \uc0c8\ub85c\uc6b4 \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c\uc758 \ube60\ub978 \ucc44\ud0dd\uc744 \uc8fc\ub3c4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. 2025\ub144 1\uc6d4 \ud3ec\uc2a4\ub514\ub124\ub9d9(posdinemab)\uacfc \ud2f0\ube44\ub370\ub178\ud478\uc2a4\ud504 \uc54c\ud30c(tividenofusp alfa)\uc5d0 \ub300\ud55c \ud601\uc2e0 \uce58\ub8cc\uc81c \uc9c0\uc815\uc740 \uaddc\uc81c \ubbfc\ucca9\uc131\uc744 \ubcf4\uc5ec\uc90d\ub2c8\ub2e4. \ubca4\ucc98 \uce90\ud53c\ud0c8\uc740 \ubcf4\uc2a4\ud134\uacfc \uc0cc\ud504\ub780\uc2dc\uc2a4\ucf54 \ud5c8\ube0c\ub85c \uc720\uc785\ub418\uace0 \uc788\uc73c\uba70, \ub85c\uc288\uc758 500\uc5b5 \ub2ec\ub7ec \ubbf8\uad6d \ud655\uc7a5 \ud22c\uc790\ub294 \uad6d\ub0b4 \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c \uc0dd\uc0b0 \uc5ed\ub7c9\uc744 \ud655\ubcf4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591: 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 8.31%\ub85c \uac00\uc7a5 \ube60\ub978 \uc131\uc7a5\ub960\uc744 \ubcf4\uc77c \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc77c\ubcf8\uc758 \ub808\ucf10\ube44 \ube60\ub978 \ucc44\ud0dd\uc740 \uc608\uc0b0 \uc2ec\uc0ac\uc5d0\ub3c4 \ubd88\uad6c\ud558\uace0 \uace0\uac00 \ud56d\uccb4\uc5d0 \ub300\ud55c \ubcf4\ud5d8 \uc801\uc6a9\uc758 \uc9c0\uc5ed\uc801 \uc120\ub840\ub97c \ub9cc\ub4e4\uc5c8\uc2b5\ub2c8\ub2e4. \uc911\uad6d\uc740 \uc6b0\uc120 \uc2ec\uc0ac \ucc44\ub110\uc744 \ud1b5\ud574 \uc2e0\uc57d \ud5c8\uac00 \uc2ec\uc0ac\ub97c \uac00\uc18d\ud654\ud558\uace0 \uc788\uc73c\uba70, \ud604\uc9c0 \uae30\uc5c5\ub4e4\uc740 \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec \ubc0f RNA \uce58\ub8cc\uc81c\ub97c \uacf5\ub3d9 \uac1c\ubc1c\ud558\uc5ec \uc9c4\uc785 \uac00\uaca9\uc744 \ub0ae\ucd94\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ud55c\uad6d\uc740 AI \uae30\ubc18 \uac80\uc9c4 \ub3c4\uad6c\uc5d0 \uc790\uae08\uc744 \uc9c0\uc6d0\ud558\uace0 \uc788\uc73c\uba70, \ud638\uc8fc\ub294 \uc720\uc804\uccb4 \uac80\uc0ac\ub97c \uacf5\uacf5 \ubcf4\uac74 \ud61c\ud0dd\uc5d0 \ud1b5\ud569\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc720\ub7fd: EMA\uc758 \uc911\uc559 \uc9d1\uc911\uc2dd \uc808\ucc28\uc5d0 \ud798\uc785\uc5b4 \uafb8\uc900\ud55c \uc131\uc7a5\uc744 \ubcf4\uc774\uace0 \uc788\uc73c\uba70, \uc774\ub294 \uc704\ud5d8\uacfc \uc811\uadfc\uc131 \uc0ac\uc774\uc758 \uade0\ud615\uc744 \ub9de\ucda5\ub2c8\ub2e4. \ub3c5\uc77c, \ud504\ub791\uc2a4, \uc601\uad6d\uc740 \ud504\ub9ac\ubbf8\uc5c4 \uc2dc\uc7a5\uc73c\ub85c \ub0a8\uc544 \uc788\uc9c0\ub9cc, \uc9c0\ucd9c\uc744 \uc5b5\uc81c\ud558\uae30 \uc704\ud574 \uc131\uacfc \uae30\ubc18 \ub9ac\ubca0\uc774\ud2b8\ub97c \ud611\uc0c1\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ub0a8\uc720\ub7fd\uc740 EU \uacb0\uc18d \uae30\uae08\uc73c\ub85c \uacf5\ub3d9 \uc790\uae08\uc744 \uc9c0\uc6d0\ubc1b\ub294 \uc9c0\uc5ed \uce58\ub9e4 \uacc4\ud68d \ubc30\ud3ec\ub97c \ub298\ub824 \uc870\uae30 \uc9c4\ub2e8 \ubc0f \uc9c8\ubcd1 \uc9c4\ud589 \ub454\ud654\ub97c \uc9c0\uc6d0\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p># 6. \uacbd\uc7c1 \ud658\uacbd (Competitive Landscape)<\/p>\n<p>\uc2dc\uc7a5 \uad6c\uc870\ub294 \uc0c1\uc704 \ub2e4\uad6d\uc801 \uae30\uc5c5\ub4e4\uc774 \ud2b9\ud5c8 \uc790\uc0b0\uacfc \uc720\ud1b5\ub825\uc744 \ud65c\uc6a9\ud558\uace0 \uc788\uc74c\uc5d0\ub3c4 \ubd88\uad6c\ud558\uace0, \ub2e8\uc77c \uae30\uc5c5\uc774 3\ubd84\uc758 1 \uc774\uc0c1\uc758 \uc810\uc720\uc728\uc744 \ucd08\uacfc\ud558\uc9c0 \uc54a\ub294 \uc911\uac04 \uc815\ub3c4\uc758 \uc9d1\uc911\ub3c4\ub97c \uc720\uc9c0\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ubc14\uc774\uc624\uc820(Biogen), \ub85c\uc288(Roche), \uc77c\ub77c\uc774 \ub9b4\ub9ac(Eli Lilly), \uc5d0\uc790\uc774(Eisai), \ub178\ubc14\ud2f0\uc2a4(Novartis)\ub294 \ube0c\ub79c\ub4dc \ub9e4\ucd9c\uc758 \uc57d 62%\ub97c \ucc28\uc9c0\ud558\uace0 \uc788\uc73c\uba70, \ubca4\ucc98 \uc9c0\uc6d0 \uc2e0\uaddc \uae30\uc5c5\ub4e4\uc5d0\uac8c \ucda9\ubd84\ud55c \uc131\uc7a5 \uc5ec\uc9c0\ub97c \ub0a8\uaca8\ub450\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc804\ub7b5\uc801 \uc81c\ud734\uac00 \uac70\ub798 \ud750\ub984\uc744 \uc9c0\ubc30\ud558\uba70, \ubc14\uc774\uc624\uc820-\ub124\uc624\ubaa8\ud504(Biogen\u2013Neomorph)\uc758 14\uc5b5 5\ucc9c\ub9cc \ub2ec\ub7ec \ub2e8\ubc31\uc9c8 \ubd84\ud574\uc81c \uacc4\uc57d\uacfc \ub178\ubc14\ud2f0\uc2a4-\ubc14\uc774\uc624\uc5d0\uc774\uc9c0(Novartis\u2013BioAge)\uc758 5\uc5b5 3\ucc9c\ub9cc \ub2ec\ub7ec \uc7a5\uc218 \ud611\ub825\uc774 \ub300\ud45c\uc801\uc785\ub2c8\ub2e4. M&#038;A \ud65c\ub3d9\uc740 \uc560\ube0c\ube44(AbbVie)\uc758 87\uc5b5 \ub2ec\ub7ec \uc138\ub808\ubca8(Cerevel) \uc778\uc218\uc640 \uc874\uc2a8\uc564\ub4dc\uc874\uc2a8(Johnson &#038; Johnson)\uc758 146\uc5b5 \ub2ec\ub7ec \uc778\ud2b8\ub77c\uc140\ub8f0\ub7ec \ud14c\ub77c\ud53c\uc2a4(Intra-Cellular Therapies) \uc778\uc218\ub85c \ubc18\ub4f1\ud588\uc73c\uba70, \uc774\ub294 \uc704\ud5d8\uc774 \uc644\ud654\ub41c 2\uc0c1 \uc790\uc0b0\uc5d0 \ub300\ud55c \uc218\uc694\ub97c \ubc18\uc601\ud569\ub2c8\ub2e4.<\/p>\n<p>AI\ub97c \ud65c\uc6a9\ud55c \uc2e0\uaddc \ud45c\uc801 \ubc1c\uad74 \ubc0f \ud654\ud559 \uc6cc\ud06c\ud50c\ub85c\uc6b0 \uac00\uc18d\ud654 \ud50c\ub7ab\ud3fc\uc740 \uae30\uc874 \uae30\uc5c5\uc758 \uaddc\ubaa8 \uc6b0\uc704\uc5d0 \ub3c4\uc804\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc194\ub9ac\ub4dc \ubc14\uc774\uc624\uc0ac\uc774\uc5b8\uc2a4(Solid Biosciences)\uc758 FDA \uc2b9\uc778\uacfc \uc548\ub178\ube44\uc2a4 \ubc14\uc774\uc624(Annovis Bio)\uc758 3\uc0c1 \uc2b9\uc778\uc740 \uaddc\uc81c \ub2f9\uad6d\uc774 \uc124\ub4dd\ub825 \uc788\ub294 \uacfc\ud559\uc744 \uac00\uc9c4 \uc18c\uaddc\ubaa8 \uc2a4\ud3f0\uc11c\uc5d0\uac8c\ub3c4 \uae30\ud68c\ub97c \uc81c\uacf5\ud560 \uc758\uc9c0\uac00 \uc788\uc74c\uc744 \ubcf4\uc5ec\uc90d\ub2c8\ub2e4. \ud55c\ud3b8, \ub300\ud615 \uc81c\uc57d\uc0ac\ub4e4\uc740 \uc9c4\ub2e8 \ubc0f \ub514\uc9c0\ud138 \ud5ec\uc2a4\ucf00\uc5b4 \ubd84\uc57c\ub85c \ub2e4\uac01\ud654\ud558\uc5ec \uc5d4\ub4dc \ud22c \uc5d4\ub4dc \uac00\uce58 \ud655\ubcf4\ub97c \ucd94\uc9c4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc804\ubc18\uc801\uc73c\ub85c \uc5ed\ub3d9\uc801\uc778 \ud611\ub825, \uc120\ubcc4\uc801 \ud1b5\ud569, \uadf8\ub9ac\uace0 \uad50\ucc28 \ubd80\ubb38 \uc735\ud569\uc774 \uc2e0\uacbd\ud1f4\ud589\uc131 \uc9c8\ud658 \uc2dc\uc7a5\uc758 \uacbd\uc7c1 \uad6c\ub3c4\ub97c \ud615\uc131\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uc2dc\uc7a5 \ucc38\uc5ec \uae30\uc5c5:<br \/>\n*   Boehringer Ingelheim International GmbH<br \/>\n*   UCB SA<br \/>\n*   Novartis AG<br \/>\n*   Merck &#038; Co Inc.<br \/>\n*   Teva Pharmaceuticals, Inc.<\/p>\n<p># 7. \ucd5c\uadfc \uc0b0\uc5c5 \ub3d9\ud5a5 (Recent Industry Developments)<\/p>\n<p>*   2026\ub144 1\uc6d4: NRG Therapeutics\ub294 ALS\/\ud30c\ud0a8\uc2a8\ubcd1 \uce58\ub8cc\uc81c NRG5051\uc758 1\uc0c1 \uc784\uc0c1\uc2dc\ud5d8 \uccab \ucc38\uac00\uc790 \ud22c\uc5ec\ub97c \uc2dc\uc791\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   2026\ub144 1\uc6d4: Ipsen\uc740 Origami Therapeutics\uc640 \uc720\uc804\uc131 \uc2e0\uacbd\ud1f4\ud589\uc131 \uc9c8\ud658 \ub2e8\ubc31\uc9c8 \ubd84\ud574\uc81c\uc5d0 \ub300\ud55c \uae00\ub85c\ubc8c \uc635\uc158 \uacc4\uc57d\uc744 \uccb4\uacb0\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   2025\ub144 12\uc6d4: SciNeuro Pharmaceuticals\ub294 Lp-PLA2, \ubca0\ud0c0-\uc544\ubc00\ub85c\uc774\ub4dc, LRRK2 \ud504\ub85c\uadf8\ub7a8 \uac1c\ubc1c\uc744 \uc704\ud55c 5,300\ub9cc \ub2ec\ub7ec \uc790\uae08 \uc870\ub2ec\uc744 \uc644\ub8cc\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   2025\ub144 6\uc6d4: Roche\ub294 \uae0d\uc815\uc801\uc778 \uc911\uac04 \ub2e8\uacc4 \ub370\uc774\ud130\uc5d0 \ub530\ub77c \ud30c\ud0a8\uc2a8\ubcd1 \ud6c4\ubcf4 \ubb3c\uc9c8\uc744 3\uc0c1\uc73c\ub85c \uc9c4\uc785\uc2dc\ucf30\uc2b5\ub2c8\ub2e4.<br \/>\n*   2024\ub144 12\uc6d4: Lantheus\ub294 Life Molecular Imaging\uc744 12\uc5b5 7\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0 \uc778\uc218 \uc644\ub8cc\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   2024\ub144 11\uc6d4: Johnson &#038; Johnson\uc740 Intra-Cellular Therapies\ub97c 146\uc5b5 \ub2ec\ub7ec\uc5d0 \uc778\uc218 \ubc1c\ud45c\ud588\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\ubcf8 \ubcf4\uace0\uc11c\ub294 \ub1cc \uc2e0\uacbd\uc138\ud3ec\uc5d0 \uc601\ud5a5\uc744 \ubbf8\uce58\ub294 \ub2e4\uc591\ud55c \uc9c8\ud658\uc744 \ud3ec\uad04\ud558\ub294 \uc2e0\uacbd\ud1f4\ud589\uc131 \uc9c8\ud658 \uc2dc\uc7a5\uc5d0 \ub300\ud55c \uc2ec\uce35 \ubd84\uc11d\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4. \uc2e0\uacbd\ud1f4\ud589\uc131 \uc9c8\ud658\uc740 \ud604\uc7ac \uc644\uce58\ubc95\uc774 \uc5c6\uc73c\uba70, \uc2e0\uacbd\uc138\ud3ec\uc758 \uc810\uc9c4\uc801\uc778 \uc0ac\uba78\uc744 \ud2b9\uc9d5\uc73c\ub85c \ud569\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uaddc\ubaa8\ub294 2026\ub144 632.1\uc5b5 \ub2ec\ub7ec\uc5d0 \ub2ec\ud588\uc73c\uba70, 2031\ub144\uc5d0\ub294 888.3\uc5b5 \ub2ec\ub7ec\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \uc774\ub294 \ud574\ub2f9 \uae30\uac04 \ub3d9\uc548 \uacac\uace0\ud55c \uc131\uc7a5\uc138\ub97c \ubcf4\uc77c \uac83\uc784\uc744 \uc2dc\uc0ac\ud569\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uc2dc\uc7a5 \uc131\uc7a5 \ub3d9\ub825\uc73c\ub85c\ub294 \uace0\ub839\ud654 \uc778\uad6c \uc99d\uac00\uc640 \uc9c8\ubcd1 \ubd80\ub2f4 \uc2ec\ud654, \uc9c8\ubcd1 \uc870\uc808 \uce58\ub8cc\uc81c(DMT)\uc758 \ucd9c\uc2dc \ubc0f \ubcf4\ud5d8 \uc801\uc6a9 \ud655\ub300, \uc2e0\uacbd \uc601\uc0c1 \ubc0f \ud608\uc561 \uae30\ubc18 \ubc14\uc774\uc624\ub9c8\ucee4 \uae30\uc220 \ubc1c\uc804, \uc2e0\uacbd\uacfc\ud559 R&#038;D \ud22c\uc790 \ud655\ub300, AI \uae30\ubc18 \uc2e0\uaddc \ud45c\uc801 \ubc1c\uad74 \uac00\uc18d\ud654, \ub1cc\ud608\uad00\uc7a5\ubcbd(BBB) \ud22c\uacfc\uc728\uc744 \ub192\uc774\ub294 \ub1cc \ud45c\uc801 \uc57d\ubb3c \uc804\ub2ec \ud50c\ub7ab\ud3fc \uac1c\ubc1c \ub4f1\uc774 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\ubc18\uba74, \ud6c4\uae30 \uc784\uc0c1\uc2dc\ud5d8\uc5d0\uc11c\uc758 \ub192\uc740 \uc2e4\ud328\uc728, \ucca8\ub2e8 \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c \ubc0f \uc720\uc804\uc790 \uce58\ub8cc\uc81c\uc758 \ub192\uc740 \uac00\uaca9, \uc2e0\ud765 \uc2dc\uc7a5\uc758 \uc81c\ud55c\uc801\uc778 \ubc14\uc774\uc624\ub9c8\ucee4 \uc778\ud504\ub77c, \ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130 \uc81c\uc870 \uacf5\uae09\ub9dd \ubcd1\ubaa9 \ud604\uc0c1 \ub4f1\uc740 \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc800\ud574\ud558\ub294 \uc694\uc778\uc73c\ub85c \uc791\uc6a9\ud569\ub2c8\ub2e4. \ud2b9\ud788, \uc0dd\ubb3c\ud559\uc801 \ubcf5\uc7a1\uc131\uacfc \uc784\uc0c1 \ud3c9\uac00 \uc9c0\ud45c \uce21\uc815\uc758 \uc5b4\ub824\uc6c0\uc73c\ub85c \uc778\ud574 3\uc0c1 \uc784\uc0c1\uc2dc\ud5d8\uc758 \uc2e4\ud328\uc728\uc774 85%\ub97c \ucd08\uacfc\ud558\ub294 \uac83\uc73c\ub85c \ub098\ud0c0\ub0ac\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5\uc740 \uc801\uc751\uc99d, \uc57d\ubb3c \uc885\ub958, \ubd84\uc790 \uc720\ud615, \ud22c\uc5ec \uacbd\ub85c, \uc720\ud1b5 \ucc44\ub110 \ubc0f \uc9c0\uc5ed\ubcc4\ub85c \uc138\ubd84\ud654\ub418\uc5b4 \ubd84\uc11d\ub429\ub2c8\ub2e4. \uc801\uc751\uc99d\ubcc4\ub85c\ub294 \ud30c\ud0a8\uc2a8\ubcd1, \uc54c\uce20\ud558\uc774\uba38\ubcd1, \ub2e4\ubc1c\uc131 \uacbd\ud654\uc99d, \ud5cc\ud305\ud134\ubcd1, \ub8e8\uac8c\ub9ad\ubcd1(ALS), \uc804\uce21\ub450\uc5fd \uce58\ub9e4, \ucc99\uc218\uc131 \uadfc\uc704\ucd95\uc99d(SMA) \ubc0f \uae30\ud0c0 \ud76c\uadc0 \uc2e0\uacbd\ud1f4\ud589\uc131 \uc9c8\ud658\uc744 \ud3ec\ud568\ud569\ub2c8\ub2e4. \uc774 \uc911 \uc54c\uce20\ud558\uc774\uba38\ubcd1\uc740 2025\ub144 \uc804 \uc138\uacc4 \ub9e4\ucd9c\uc758 41.72%\ub97c \ucc28\uc9c0\ud558\uba70 \uc2dc\uc7a5\uc744 \uc8fc\ub3c4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc57d\ubb3c \uc885\ub958\ubcc4\ub85c\ub294 NMDA \uc218\uc6a9\uccb4 \uae38\ud56d\uc81c, \ucf5c\ub9b0\uc5d0\uc2a4\ud14c\ub77c\uc81c \uc5b5\uc81c\uc81c, \ub3c4\ud30c\ubbfc \uc791\uc6a9\uc81c, \uba74\uc5ed\uc870\uc808\uc81c\/\ub2e8\uc77c\ud074\ub860\ud56d\uccb4, \uc720\uc804\uc790 \ubc0f \uc138\ud3ec \uce58\ub8cc\uc81c, \uc548\ud2f0\uc13c\uc2a4 \uc62c\ub9ac\uace0\ub274\ud074\ub808\uc624\ud0c0\uc774\ub4dc \ubc0f RNAi \ub4f1\uc774 \ud3ec\ud568\ub429\ub2c8\ub2e4. \uc720\uc804\uc790 \ubc0f \uc138\ud3ec \uce58\ub8cc\uc81c\ub294 \uc5f0\ud3c9\uade0 9.21%\uc758 \uac00\uc7a5 \ube60\ub978 \uc131\uc7a5\ub960\uc744 \ubcf4\uc774\uba70 \uc8fc\ubaa9\ud560 \ub9cc\ud55c \ubd80\ubb38\uc73c\ub85c \ubd80\uc0c1\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ubd84\uc790 \uc720\ud615\uc740 \uc18c\ubd84\uc790 \uc57d\ubb3c, \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c \ubc0f \ub2e8\uc77c\ud074\ub860\ud56d\uccb4, RNA \uae30\ubc18 \uce58\ub8cc\uc81c \ub4f1\uc73c\ub85c \uad6c\ubd84\ub429\ub2c8\ub2e4. \ud22c\uc5ec \uacbd\ub85c\ub294 \uacbd\uad6c, \ube44\uacbd\uad6c(\uc815\ub9e5\/\ud53c\ud558), \uacbd\ud53c\/\ube44\uac15, \uc218\ub9c9\uac15\ub0b4 \uc8fc\uc785, \uc9d1\uc911 \ucd08\uc74c\ud30c \ub9e4\uac1c \uc804\ub2ec \ub4f1\uc744 \ud3ec\ud568\ud569\ub2c8\ub2e4.<\/p>\n<p>\uc720\ud1b5 \ucc44\ub110\uc740 \ubcd1\uc6d0 \uc57d\uad6d, \uc18c\ub9e4 \ubc0f \uc804\ubb38 \uc57d\uad6d, \uc628\ub77c\uc778 \uc57d\uad6d\uc73c\ub85c \uad6c\uc131\ub418\uba70, \uc628\ub77c\uc778 \uc57d\uad6d\uc740 \uc6d0\uaca9 \uc758\ub8cc \ubc0f \uc804\uc790 \ucc98\ubc29\uc804\uc758 \ubc1c\uc804\uc73c\ub85c 10.08%\uc758 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960\uc744 \uae30\ub85d\ud558\uba70 \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc9c0\uc5ed\ubcc4\ub85c\ub294 \ubd81\ubbf8, \uc720\ub7fd, \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591, \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74, \ub0a8\ubbf8\ub85c \uad6c\ubd84\ub418\uba70, \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc740 \uace0\ub839\ud654 \uc778\uad6c \uc99d\uac00\uc640 \uc811\uadfc\uc131 \uac1c\uc120\uc5d0 \ud798\uc785\uc5b4 8.31%\uc758 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<\/p>\n<p>\uacbd\uc7c1 \ud658\uacbd \ubd84\uc11d\uc740 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4, \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d \ubc0f \uc8fc\uc694 \uae30\uc5c5 \ud504\ub85c\ud544\uc744 \ud3ec\ud568\ud558\uba70, AbbVie, Biogen, Eisai, Eli Lilly, Roche, Novartis, Pfizer \ub4f1 \ub2e4\uc218\uc758 \uae00\ub85c\ubc8c \uc81c\uc57d\uc0ac\ub4e4\uc774 \uc2dc\uc7a5\uc5d0 \ucc38\uc5ec\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ubcf4\uace0\uc11c\ub294 \ub610\ud55c \uc2dc\uc7a5 \uae30\ud68c\uc640 \ubbf8\ub798 \uc804\ub9dd, \ubbf8\ucda9\uc871 \uc218\uc694 \ud3c9\uac00\ub97c \ud1b5\ud574 \ud5a5\ud6c4 \uc2dc\uc7a5\uc758 \ubc29\ud5a5\uc131\uc744 \uc81c\uc2dc\ud569\ub2c8\ub2e4.<\/p>\n<p>\uc885\ud569\uc801\uc73c\ub85c, \uc2e0\uacbd\ud1f4\ud589\uc131 \uc9c8\ud658 \uc2dc\uc7a5\uc740 \uace0\ub839\ud654\uc640 \uae30\uc220 \ubc1c\uc804\uc774\ub77c\ub294 \uac15\ub825\ud55c \ub3d9\ub825\uc5d0 \ud798\uc785\uc5b4 \uc9c0\uc18d\uc801\uc778 \uc131\uc7a5\uc774 \uc608\uc0c1\ub418\ub098, \ub192\uc740 \uac1c\ubc1c \ube44\uc6a9\uacfc \uc784\uc0c1 \uc2e4\ud328\uc728\uc774\ub77c\ub294 \ub3c4\uc804 \uacfc\uc81c\ub97c \uc548\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-48439","post","type-post","status-publish","format-standard","hentry","category-market-reports"],"_links":{"self":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/48439"}],"collection":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/comments?post=48439"}],"version-history":[{"count":0,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/48439\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/media?parent=48439"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/categories?post=48439"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/tags?post=48439"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}